Non-infected babies born to HIV mothers have reduced immunity to measles

October 18, 2012

Non-infected babies born to HIV positive mothers should be vaccinated early against measles, to avoid them acquiring the virus or passing it on to others.

A study published in the November issue of Acta Paediatrica found that even if babies are born without HIV, their maternally derived protection against measles may be impaired by their mother's positive HIV status.

"The eradication of measles is high on the agendas of the World Health Organization and other international agencies and it is important to define and target any new group of susceptible infants" says Dr Lars Smedman from the Department of Paediatrics at Karolinska University Hospital, Stockholm, Sweden.

According to the World Health Organization, measles is one of the leading causes of death among young children. Complications of this highly contagious, serious disease can include bacterial pneumonia, blindness, destructive ear infections, severe diarrhoea and related dehydration.

In 2010 there were 139,300 deaths globally, which equates to 380 a day or 15 an hour. However, in 1980, before widespread immunisation, measles caused an estimated 2.6 million deaths a year. Immunisations have risen by 72% since 2000 and in 2010 about 85 per cent of the World's children received one dose of the measles vaccine by their first birthday.

Dr Smedman and colleagues compared blood serum samples from ten babies aged one to four months who were born to HIV mothers, but had not acquired the infection, to ten healthy babies born to mothers without HIV.

The mothers ranged from 26 to 35 years of age, were all immigrants and originated from Ethiopia, the Ivory Coast, Uganda, Kenya and Thailand. Their viral loads ranged from less than 20 to 8,870 and their CD4 cell counts from 237 to 754.

Nine gave birth by planned or emergency caesarean, with only one vaginal birth, and the gestational age of the babies ranged from 32 to 41 weeks.

"We used a new cell ELISA technique to demonstrate how the serum samples drawn from the infants would inactivate the measles virus" explains Dr Smedman.

"This found statistically significant differences between the maternal antibodies received by the two sets of babies and showed that the non-infected babies born to HIV positive mothers had weaker protection. This was because the antibodies normally produced by the mother to help protect her baby from measles had lost their sharp edge due to her HIV positive status.

"The results suggest that babies born to HIV mothers would not be able to neutralise the measles virus as effectively and would loose protection sooner than babies born to healthy mothers. These babies would therefore be much more likely to succumb to measles and, or, pass the virus on to other children, making their early immunisation vital."
-end-
The paper is free online at: http://onlinelibrary.wiley.com/doi/10.1111/j.1651-2227.2012.02793.x/abstract

Notes to editors

Wiley

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.